Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Novozymes Biopharma has entered a new collaborative research agreement with one of the world’s top vaccine companies. The partnership will enable the company to evaluate Novozymes Biopharma's modified recombinant human albumin (rAlbumin) Veltis ...
read more
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today an exclusive manufacturing license and supply agreement that will allow Sigma-Aldrich to manufacture...
read more
Richman Chemical, Inc. today announced a new Consulting Services Division to assist chemistry-based startups with evaluating new technologies and establishing strategic relationships with service providers, regulatory experts, technology licensing ...
read more
CMC Biologics, Inc., a global leader in process development and contract
manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company
focused on discovering and developing innovative monoclonal antibody-based ...
read more
(BUSINESS WIRE) – Ash Stevens, Inc., a leading provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, is pleased to announce receipt of a 2014 Lilly Global Supplier ...
read more
Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel’s Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only investigational oral form of octreotide in clinical development. The drug candidate is in ...
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces a development and manufacturing agreement with Selexys Pharmaceuticals, Corp., an Oklahoma City-based clinical stage ...
read more
ISPE, the International Society for Pharmaceutical Engineering, announced today that it will work with stakeholders world-wide to produce a Drug Shortages Prevention Plan to guide the pharmaceutical and biopharmaceutical industry in establishing ...
read more
Molecular Profiles Ltd., a subsidiary of Columbia Laboratories, Inc., (Nasdaq: CBRX), is set to increase awareness and uptake of its pharmaceutical development services in the North American market following the appointment of a new head of US sales.
read more
Quotient Clinical, the Translational Pharmaceutics Company, has announced the extension of its Translational Pharmaceutics™ platform into patient-focused cancer drug development. Quotient will employ its real-time, flexible manufacturing capabilities...
read more
Sigma-Aldrich® Corporation's (NASDAQ: SIAL) custom manufacturing and services business unit, SAFC Commercial (www.sigma-aldrich.com/safc), has entered into a collaborative technology agreement with BioTools Inc. (www.btools.com). The partnership ...
read more
Chemic Laboratories Inc. and ASI today announced
establishment of a formal three year Joint Cooperation Agreement that will enable the two firms
to collaborate on a variety of Pharmaceutical and Biopharmaceutical client interests, primarily in
the...
read more
Akorn, Inc. today announced that it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million in cash.
read more
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced it has successfully introduced serialisation services and initiated commercial production of two anti-allergy product lines for the ...
read more
AIT Laboratories (AIT) has named Kun Ma, MD, Ph.D., MBA to the position of vice president of science and technology. Dr. Ma comes to the company after most recently serving as director of venture analysis at CHV Capital, Inc., and president and CEO ...
read more